OMERS ADMINISTRATION Corp bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,393 shares of the company's stock, valued at approximately $4,832,000.
A number of other institutional investors have also recently bought and sold shares of HCA. Osmosis Investment Management UK Ltd bought a new position in shares of HCA Healthcare in the 2nd quarter worth $1,794,000. Sanctuary Advisors LLC bought a new position in HCA Healthcare during the second quarter worth about $3,814,000. Solstein Capital LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $58,000. Meiji Yasuda Asset Management Co Ltd. acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $996,000. Finally, Te Ahumairangi Investment Management Ltd acquired a new position in HCA Healthcare during the second quarter valued at approximately $5,104,000. Institutional investors and hedge funds own 62.73% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently weighed in on HCA. Royal Bank Of Canada reissued an "outperform" rating and set a $435.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Stephens reduced their target price on HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating on the stock in a report on Monday, April 27th. The Goldman Sachs Group lowered their price target on HCA Healthcare from $558.00 to $485.00 and set a "buy" rating for the company in a report on Tuesday, July 28th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a research report on Monday, August 3rd. Finally, Cantor Fitzgerald dropped their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating on the stock in a report on Tuesday, July 7th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $462.64.
Read Our Latest Stock Report on HCA
HCA Healthcare Price Performance
Shares of HCA Healthcare stock opened at $429.19 on Tuesday. The firm has a market cap of $92.92 billion, a price-to-earnings ratio of 14.37, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. The stock's 50-day moving average is $397.94 and its 200-day moving average is $443.28. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter last year, the firm earned $6.84 EPS. HCA Healthcare's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 10.45%.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
